IP6 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
122脳表ヘモジデリン沈着症1

122. 脳表ヘモジデリン沈着症


臨床試験数 : 3 薬物数 : 3 - (DrugBank : 2) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04890808
(ClinicalTrials.gov)
May 202312/5/2021Therapeutic Antioxidant SupplementationTherapeutic Antioxidant Supplementation for Enhancement of Neural Protection From Free-iron Toxicity in Superficial SiderosisSuperficial SiderosisDietary Supplement: Inosine;Dietary Supplement: IP6Superficial Siderosis Research Alliance Inc.NULLNot yet recruiting16 Years77 YearsAll50N/ANULL